Delivery Order SPE2DB22D3016-SPE2DB24FAAB7

The Defense Logistics Agency awarded a $226,187.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 mg/10 ml vials. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will deliver the multiple sclerosis treatment to a facility in Conshohocken, Pennsylvania by October 17, 2023 under the prime contract vehicle. No set aside designation or subcontractors were indicated. This supports the Defense Logistics Agency's mission to provide medical...

The Defense Logistics Agency awarded a $67,856.16 firm fixed price delivery order to Amerisourcebergen Drug Corporation for OCREVUS 300 MG/10 ML vials. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will deliver the multiple sclerosis treatment to a facility in Conshohocken, Pennsylvania by August 30th, 2023 under the prime contract vehicle. No set aside designation or subcontractors were indicated. This supports the Defense Logistics Agency's mission to provide medical...

The Defense Logistics Agency awarded a $51,275.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Ocrevus 300 mg/10 mL vials. This competitive award with no set-aside designation is scheduled for completion by February 19, 2026, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical,...

<p>The Defense Logistics Agency awarded a firm fixed price delivery order valued at $67,856.16 to Amerisourcebergen Drug Corporation for the purchase of Ocrevus 300 MG/10 ML vials. Performance will take place in Conshohocken, Pennsylvania under the prime contractor's corporate office division. The order is associated with DLA's pharmaceutical procurement programs and runs from August 18 to September 11, 2023. No subcontractors or set aside designations were indicated.</p>

The Defense Logistics Agency awarded a $75,998.88 delivery order to AmerisourceBergen Drug Corp for OCREVUS 300 mg/10 ml vials on December 18, 2025, with an ultimate completion date of January 12, 2026. This is a firm fixed-price, non-set-aside contract for pharmaceutical supplies to be delivered to the place of performance in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...

The Defense Logistics Agency awarded a $76,913.10 delivery order to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of Ocrevus 300 mg/10 mL vials. This is a firm fixed-price contract with a completion date of February 23, 2026, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare...

The Defense Logistics Agency awarded a $45,237 delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. The firm fixed price order is valued at forty-five thousand two hundred thirty-seven dollars and will be performed in Conshohocken, Pennsylvania under the agency's Pharmaceutical Prime Vendor contract vehicle from August 3rd to August 24th, 2023. Amerisourcebergen will supply the multiple sclerosis treatment to the DLA, which manages the Department of Defense's...

<p>The Defense Logistics Agency (DOD) awarded a $262,342.80 firm fixed price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division to provide 4558440250 OCREVUS 300 MG/10 ML VIAL 10ML pharmaceutical products. The place of performance will be in Conshohocken, Pennsylvania and the period of performance is from September 13, 2022 through October 4, 2022. No applicable subcontractors were identified.</p>

<p>The Defense Logistics Agency (DOD) awarded a $262,342.80 firm fixed price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division to provide 4558639319 OCREVUS 300 MG/10 ML VIAL 10ML pharmaceutical products. The place of performance will be in Conshohocken, Pennsylvania and the period of performance is from September 29, 2022 through October 21, 2022. No applicable subcontractors were identified.</p>

The Defense Logistics Agency issued a $62,536.68 delivery order to Amerisourcebergen Drug Corp on March 9, 2026, for Ocrevus 300 mg/10 mL vials under a firm fixed-price arrangement. The order's ultimate completion date is March 30, 2026. Place of performance is Conshohocken, Pennsylvania. The delivery order was issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, which supports pharmaceutical supply across military healthcare systems globally. Amerisourcebergen...